Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Ellis

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
Cancer|December 21, 2019
Value assessment of oncology drugs using a weighted criterion-based approachDoreen A Ezeife, Francois Dionne, Aline Fusco Fares, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 27, 2015
MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase InhibitionMatthew J Fell, Christian Mirescu, Kallol Basu, et al.
Plos One|July 19, 2017
A human tissue-based functional assay platform to evaluate the immune function impact of small molecule inhibitors that target the immune systemCristina St Pierre, Jane Guo, John D Shin, et al.
Plos One|November 9, 2021
Small molecule allosteric inhibitors of RORγt block Th17-dependent inflammation and associated gene expression in vivoSteven A Saenz, Andrea Local, Tiffany Carr, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2015
Discovery of a new chemical series of BRD4(1) inhibitors using protein-ligand docking and structure-guided designBryan C Duffy, Shuang Liu, Gregory S Martin, et al.
Science (New York, N.Y.)|January 9, 2016
The Anthropocene is functionally and stratigraphically distinct from the HoloceneColin N Waters, Jan Zalasiewicz, Colin Summerhayes, et al.
American Journal of Respiratory Cell and Molecular Biology|July 30, 2013
Inhibition of spleen tyrosine kinase attenuates allergen-mediated airway constrictionLily Y Moy, Yanlin Jia, Michael Caniga, et al.
Journal of Neurotrauma|April 27, 2019
Practice Patterns in Pharmacological and Non-Pharmacological Therapies for Children with Mild Traumatic Brain Injury: A Survey of 15 Canadian and United States CentersRebekah Mannix, Roger Zemek, Keith Owen Yeates, et al.
Journal of Neurotrauma|February 7, 2024
Intimate Partner Violence-Related Brain Injury: Unmasking and Addressing the GapsCarrie Esopenko, Divya Jain, Shambhu Prasad Adhikari, et al.
Journal of Medicinal Chemistry|January 28, 2015
Overcoming mutagenicity and ion channel activity: optimization of selective spleen tyrosine kinase inhibitorsJ Michael Ellis, Michael D Altman, Alan Bass, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Cancer|December 21, 2019
Value assessment of oncology drugs using a weighted criterion-based approachDoreen A Ezeife, Francois Dionne, Aline Fusco Fares, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 27, 2015
MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase InhibitionMatthew J Fell, Christian Mirescu, Kallol Basu, et al.
Plos One|July 19, 2017
A human tissue-based functional assay platform to evaluate the immune function impact of small molecule inhibitors that target the immune systemCristina St Pierre, Jane Guo, John D Shin, et al.
Plos One|November 9, 2021
Small molecule allosteric inhibitors of RORγt block Th17-dependent inflammation and associated gene expression in vivoSteven A Saenz, Andrea Local, Tiffany Carr, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2015
Discovery of a new chemical series of BRD4(1) inhibitors using protein-ligand docking and structure-guided designBryan C Duffy, Shuang Liu, Gregory S Martin, et al.
Science (New York, N.Y.)|January 9, 2016
The Anthropocene is functionally and stratigraphically distinct from the HoloceneColin N Waters, Jan Zalasiewicz, Colin Summerhayes, et al.
American Journal of Respiratory Cell and Molecular Biology|July 30, 2013
Inhibition of spleen tyrosine kinase attenuates allergen-mediated airway constrictionLily Y Moy, Yanlin Jia, Michael Caniga, et al.
Journal of Neurotrauma|April 27, 2019
Practice Patterns in Pharmacological and Non-Pharmacological Therapies for Children with Mild Traumatic Brain Injury: A Survey of 15 Canadian and United States CentersRebekah Mannix, Roger Zemek, Keith Owen Yeates, et al.
Journal of Neurotrauma|February 7, 2024
Intimate Partner Violence-Related Brain Injury: Unmasking and Addressing the GapsCarrie Esopenko, Divya Jain, Shambhu Prasad Adhikari, et al.
Journal of Medicinal Chemistry|January 28, 2015
Overcoming mutagenicity and ion channel activity: optimization of selective spleen tyrosine kinase inhibitorsJ Michael Ellis, Michael D Altman, Alan Bass, et al.
Pageof 13